BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moody TW, Ramos-Alvarez I, Jensen RT. Neuropeptide G Protein-Coupled Receptors as Oncotargets. Front Endocrinol (Lausanne) 2018;9:345. [PMID: 30008698 DOI: 10.3389/fendo.2018.00345] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Shin Y, Jung W, Kim MY, Shin D, Kim GH, Kim CH, Park SH, Cho EH, Choi DW, Han CJ, Lee KH, Kim SB, Shin HJ. NPFFR2 Contributes to the Malignancy of Hepatocellular Carcinoma Development by Activating RhoA/YAP Signaling. Cancers (Basel) 2022;14. [PMID: 36497331 DOI: 10.3390/cancers14235850] [Reference Citation Analysis]
2 Wang Y, Zhang C, Ji C, Jin W, He X, Yu S, Guo R. Molecular subtypes based on cuproptosis-related genes and immune profiles in lung adenocarcinoma. Front Genet 2022;13:1006938. [DOI: 10.3389/fgene.2022.1006938] [Reference Citation Analysis]
3 Granados-Soler JL, Taher L, Beck J, Bornemann-Kolatzki K, Brenig B, Nerschbach V, Ferreira F, Junginger J, Hewicker-Trautwein M, Murua Escobar H, Nolte I. Transcription profiling of feline mammary carcinomas and derived cell lines reveals biomarkers and drug targets associated with metabolic and cell cycle pathways. Sci Rep 2022;12:17025. [PMID: 36220861 DOI: 10.1038/s41598-022-20874-5] [Reference Citation Analysis]
4 Lee L, Ramos-Alvarez I, Jensen RT. Predictive Factors for Resistant Disease with Medical/Radiologic/Liver-Directed Anti-Tumor Treatments in Patients with Advanced Pancreatic Neuroendocrine Neoplasms: Recent Advances and Controversies. Cancers (Basel) 2022;14:1250. [PMID: 35267558 DOI: 10.3390/cancers14051250] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Gao Z, Lei WI, Lee LTO. The Role of Neuropeptide-Stimulated cAMP-EPACs Signalling in Cancer Cells. Molecules 2022;27:311. [PMID: 35011543 DOI: 10.3390/molecules27010311] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Fandel TM, Blevins LS. Growth Hormone-Releasing Hormone-Secreting Neuroendocrine Tumors. Acromegaly 2022. [DOI: 10.1007/978-3-031-16258-9_2] [Reference Citation Analysis]
7 Kasprzak A. Somatostatin and Its Receptor System in Colorectal Cancer. Biomedicines 2021;9:1743. [PMID: 34829972 DOI: 10.3390/biomedicines9111743] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Moody TW, Lee L, Ramos-Alvarez I, Iordanskaia T, Mantey SA, Jensen RT. Bombesin Receptor Family Activation and CNS/Neural Tumors: Review of Evidence Supporting Possible Role for Novel Targeted Therapy. Front Endocrinol (Lausanne) 2021;12:728088. [PMID: 34539578 DOI: 10.3389/fendo.2021.728088] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
9 Machado JF, Correia JDG, Morais TS. Emerging Molecular Receptors for the Specific-Target Delivery of Ruthenium and Gold Complexes into Cancer Cells. Molecules 2021;26:3153. [PMID: 34070457 DOI: 10.3390/molecules26113153] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
10 Moody TW, Jensen RT. Pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide [Part 1]: biology, pharmacology, and new insights into their cellular basis of action/signaling which are providing new therapeutic targets. Curr Opin Endocrinol Diabetes Obes 2021;28:198-205. [PMID: 33449573 DOI: 10.1097/MED.0000000000000617] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
11 Klingler M, Hörmann AA, Guggenberg EV. Cholecystokinin-2 Receptor Targeting with Radiolabeled Peptides: Current Status and Future Directions. Curr Med Chem 2020;27:7112-32. [PMID: 32586246 DOI: 10.2174/0929867327666200625143035] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
12 da Silva VB, e Silva FAM, Garcia CB, Leopoldino AM, da Silva CHTDP, Taft CA. Anticancer Lead Compounds that Prevent DNA Binding to hnRNP K. Functional Properties of Advanced Engineering Materials and Biomolecules 2021. [DOI: 10.1007/978-3-030-62226-8_23] [Reference Citation Analysis]
13 Maina T, Thakur M. SPECT Radiochemistry. Molecular Imaging 2021. [DOI: 10.1016/b978-0-12-816386-3.00023-5] [Reference Citation Analysis]
14 Moody TW, Ramos-Alvarez I, Jensen RT. Bombesin, endothelin, neurotensin and pituitary adenylate cyclase activating polypeptide cause tyrosine phosphorylation of receptor tyrosine kinases. Peptides 2021;137:170480. [PMID: 33385499 DOI: 10.1016/j.peptides.2020.170480] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Costanzi E, Simioni C, Conti I, Laface I, Varano G, Brenna C, Neri LM. Two neuroendocrine G protein-coupled receptor molecules, somatostatin and melatonin: Physiology of signal transduction and therapeutic perspectives. J Cell Physiol 2021;236:2505-18. [PMID: 32989768 DOI: 10.1002/jcp.30062] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
16 Moody TW, Lee L, Jensen RT. The G Protein–Coupled Receptor PAC1 Regulates Transactivation of the Receptor Tyrosine Kinase HER3. J Mol Neurosci 2021;71:1589-97. [DOI: 10.1007/s12031-020-01711-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
17 Maas M, Mayer L, Hennenlotter J, Stühler V, Walz S, Scharpf M, Kühs U, Neumann T, Stenzl A, Todenhöfer T. Prognostic impact of somatostatin receptor expression in advanced bladder cancer. Urol Oncol 2020;38:935.e17-28. [PMID: 32773234 DOI: 10.1016/j.urolonc.2020.07.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Dao T, Salahuddin S, Charfi C, Sicard A, Jenabian M, Annabi B. Pharmacological targeting of neurotensin response by diet-derived EGCG in macrophage-differentiated HL-60 promyelocytic leukemia cells. PharmaNutrition 2020;12:100191. [DOI: 10.1016/j.phanu.2020.100191] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
19 Kasprzak A, Adamek A. The Neuropeptide System and Colorectal Cancer Liver Metastases: Mechanisms and Management. Int J Mol Sci 2020;21:E3494. [PMID: 32429087 DOI: 10.3390/ijms21103494] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
20 Hoppenz P, Els-Heindl S, Kellert M, Kuhnert R, Saretz S, Lerchen HG, Köbberling J, Riedl B, Hey-Hawkins E, Beck-Sickinger AG. A Selective Carborane-Functionalized Gastrin-Releasing Peptide Receptor Agonist as Boron Delivery Agent for Boron Neutron Capture Therapy. J Org Chem 2020;85:1446-57. [PMID: 31813224 DOI: 10.1021/acs.joc.9b02406] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
21 Glumac PM, Gallant JP, Shapovalova M, Li Y, Murugan P, Gupta S, Coleman IM, Nelson PS, Dehm SM, LeBeau AM. Exploitation of CD133 for the Targeted Imaging of Lethal Prostate Cancer. Clin Cancer Res 2020;26:1054-64. [PMID: 31732520 DOI: 10.1158/1078-0432.CCR-19-1659] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
22 Roell KR, Havener TM, Reif DM, Jack J, McLeod HL, Wiltshire T, Motsinger-Reif AA. Synergistic Chemotherapy Drug Response Is a Genetic Trait in Lymphoblastoid Cell Lines. Front Genet 2019;10:829. [PMID: 31681399 DOI: 10.3389/fgene.2019.00829] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
23 Latek D, Langer I, Krzysko K, Charzewski L. A Molecular Dynamics Study of Vasoactive Intestinal Peptide Receptor 1 and the Basis of Its Therapeutic Antagonism. Int J Mol Sci 2019;20:E4348. [PMID: 31491880 DOI: 10.3390/ijms20184348] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
24 Pooja D, Gunukula A, Gupta N, Adams DJ, Kulhari H. Bombesin receptors as potential targets for anticancer drug delivery and imaging. The International Journal of Biochemistry & Cell Biology 2019;114:105567. [DOI: 10.1016/j.biocel.2019.105567] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
25 Riehle KJ, Kenerson HL, Riggle KM, Turnham R, Sullivan K, Bauer R, Scott JD, Yeung RS. Neurotensin as a source of cyclic AMP and co-mitogen in fibrolamellar hepatocellular carcinoma. Oncotarget 2019;10:5092-102. [PMID: 31489118 DOI: 10.18632/oncotarget.27149] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
26 Schuller HM. The impact of smoking and the influence of other factors on lung cancer. Expert Rev Respir Med 2019;13:761-9. [PMID: 31311354 DOI: 10.1080/17476348.2019.1645010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
27 Moody TW. Peptide receptors as cancer drug targets. Ann N Y Acad Sci 2019;1455:141-8. [PMID: 31074514 DOI: 10.1111/nyas.14100] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
28 Insel PA, Sriram K, Gorr MW, Wiley SZ, Michkov A, Salmerón C, Chinn AM. GPCRomics: An Approach to Discover GPCR Drug Targets. Trends Pharmacol Sci 2019;40:378-87. [PMID: 31078319 DOI: 10.1016/j.tips.2019.04.001] [Cited by in Crossref: 80] [Cited by in F6Publishing: 84] [Article Influence: 20.0] [Reference Citation Analysis]
29 Couvineau A, Dayot S, Nicole P, Gratio V, Rebours V, Couvelard A, Voisin T. The Anti-tumoral Properties of Orexin/Hypocretin Hypothalamic Neuropeptides: An Unexpected Therapeutic Role. Front Endocrinol (Lausanne) 2018;9:573. [PMID: 30319552 DOI: 10.3389/fendo.2018.00573] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
30 Furman B. Somatostatin Receptor Agents. Reference Module in Biomedical Sciences 2018. [DOI: 10.1016/b978-0-12-801238-3.97143-5] [Reference Citation Analysis]